Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment.

OBJECTIVE:Although milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in patients on antiretroviral therapy (ART). We examined the relationship between mild HAND and CSF neurofilament light protein (NFL), a biomar...

Full description

Bibliographic Details
Main Authors: Arvid Edén, Thomas D Marcotte, Robert K Heaton, Staffan Nilsson, Henrik Zetterberg, Dietmar Fuchs, Donald Franklin, Richard W Price, Igor Grant, Scott L Letendre, Magnus Gisslén
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4905676?pdf=render
id doaj-76e001bde3664fa9963c57abd598f660
record_format Article
spelling doaj-76e001bde3664fa9963c57abd598f6602020-11-24T21:49:12ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01116e015716010.1371/journal.pone.0157160Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment.Arvid EdénThomas D MarcotteRobert K HeatonStaffan NilssonHenrik ZetterbergDietmar FuchsDonald FranklinRichard W PriceIgor GrantScott L LetendreMagnus GisslénOBJECTIVE:Although milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in patients on antiretroviral therapy (ART). We examined the relationship between mild HAND and CSF neurofilament light protein (NFL), a biomarker of neuronal injury; and CSF neopterin, a biomarker of CNS immunoactivation, in virally suppressed patients on antiretroviral therapy (ART). DESIGN AND METHODS:We selected 99 subjects on suppressive ART followed longitudinally from the CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) study. Based on standardized comprehensive neurocognitive performance (NP) testing, subjects were classified as neurocognitively normal (NCN; n = 29) or impaired (NCI; n = 70). The NCI group included subjects with asymptomatic (ANI; n = 37) or mild (MND; n = 33) HAND. CSF biomarkers were analyzed on two occasions. RESULTS:Geometric mean CSF neopterin was 25% higher in the NCI group (p = 0.04) and NFL and neopterin were significantly correlated within the NCI group (r = 0.30; p<0.001) but not in the NCN group (r = -0.13; p = 0.3). Additionally, a trend towards higher NFL was seen in the NCI group (p = 0.06). CONCLUSIONS:Mild HAND was associated with increased intrathecal immune activation, and the correlation between neopterin and NFL found in NCI subjects indicates an association between neurocognitive impairment, CNS inflammation and neuronal damage. Together these findings suggest that NCI despite ART may represent an active pathological process within the CNS that needs further characterization in prospective studies.http://europepmc.org/articles/PMC4905676?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Arvid Edén
Thomas D Marcotte
Robert K Heaton
Staffan Nilsson
Henrik Zetterberg
Dietmar Fuchs
Donald Franklin
Richard W Price
Igor Grant
Scott L Letendre
Magnus Gisslén
spellingShingle Arvid Edén
Thomas D Marcotte
Robert K Heaton
Staffan Nilsson
Henrik Zetterberg
Dietmar Fuchs
Donald Franklin
Richard W Price
Igor Grant
Scott L Letendre
Magnus Gisslén
Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment.
PLoS ONE
author_facet Arvid Edén
Thomas D Marcotte
Robert K Heaton
Staffan Nilsson
Henrik Zetterberg
Dietmar Fuchs
Donald Franklin
Richard W Price
Igor Grant
Scott L Letendre
Magnus Gisslén
author_sort Arvid Edén
title Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment.
title_short Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment.
title_full Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment.
title_fullStr Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment.
title_full_unstemmed Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment.
title_sort increased intrathecal immune activation in virally suppressed hiv-1 infected patients with neurocognitive impairment.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2016-01-01
description OBJECTIVE:Although milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in patients on antiretroviral therapy (ART). We examined the relationship between mild HAND and CSF neurofilament light protein (NFL), a biomarker of neuronal injury; and CSF neopterin, a biomarker of CNS immunoactivation, in virally suppressed patients on antiretroviral therapy (ART). DESIGN AND METHODS:We selected 99 subjects on suppressive ART followed longitudinally from the CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) study. Based on standardized comprehensive neurocognitive performance (NP) testing, subjects were classified as neurocognitively normal (NCN; n = 29) or impaired (NCI; n = 70). The NCI group included subjects with asymptomatic (ANI; n = 37) or mild (MND; n = 33) HAND. CSF biomarkers were analyzed on two occasions. RESULTS:Geometric mean CSF neopterin was 25% higher in the NCI group (p = 0.04) and NFL and neopterin were significantly correlated within the NCI group (r = 0.30; p<0.001) but not in the NCN group (r = -0.13; p = 0.3). Additionally, a trend towards higher NFL was seen in the NCI group (p = 0.06). CONCLUSIONS:Mild HAND was associated with increased intrathecal immune activation, and the correlation between neopterin and NFL found in NCI subjects indicates an association between neurocognitive impairment, CNS inflammation and neuronal damage. Together these findings suggest that NCI despite ART may represent an active pathological process within the CNS that needs further characterization in prospective studies.
url http://europepmc.org/articles/PMC4905676?pdf=render
work_keys_str_mv AT arvideden increasedintrathecalimmuneactivationinvirallysuppressedhiv1infectedpatientswithneurocognitiveimpairment
AT thomasdmarcotte increasedintrathecalimmuneactivationinvirallysuppressedhiv1infectedpatientswithneurocognitiveimpairment
AT robertkheaton increasedintrathecalimmuneactivationinvirallysuppressedhiv1infectedpatientswithneurocognitiveimpairment
AT staffannilsson increasedintrathecalimmuneactivationinvirallysuppressedhiv1infectedpatientswithneurocognitiveimpairment
AT henrikzetterberg increasedintrathecalimmuneactivationinvirallysuppressedhiv1infectedpatientswithneurocognitiveimpairment
AT dietmarfuchs increasedintrathecalimmuneactivationinvirallysuppressedhiv1infectedpatientswithneurocognitiveimpairment
AT donaldfranklin increasedintrathecalimmuneactivationinvirallysuppressedhiv1infectedpatientswithneurocognitiveimpairment
AT richardwprice increasedintrathecalimmuneactivationinvirallysuppressedhiv1infectedpatientswithneurocognitiveimpairment
AT igorgrant increasedintrathecalimmuneactivationinvirallysuppressedhiv1infectedpatientswithneurocognitiveimpairment
AT scottlletendre increasedintrathecalimmuneactivationinvirallysuppressedhiv1infectedpatientswithneurocognitiveimpairment
AT magnusgisslen increasedintrathecalimmuneactivationinvirallysuppressedhiv1infectedpatientswithneurocognitiveimpairment
_version_ 1725888844138545152